person

Daria H. J.

Country
Poland
Department
Zakład Medycyny Nuklearnej i Endokrynologii Onkologicznej

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
54
Sites with multiple studies

Has run more than one trial at 54 of 118 partner sites.

Specializations

Prostate Cancer Treatment

This investigator specializes in advanced therapeutic approaches for prostate cancer, with particular emphasis on PSMA-targeted radioligand therapy. Their research encompasses both high-risk localized disease and metastatic cases.

  • High and Very High Risk Prostate Cancer Management
  • Systemic Adjuvant Treatments
  • Metastatic Hormone-Sensitive Prostate Cancer

Their work includes monitoring treatment outcomes through biochemical markers and radiographic progression assessment.

Neuroendocrine Oncology

The investigator conducts research in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and paragangliomas, with specific focus on pediatric and adolescent populations.

  • Somatostatin Receptor Positive Tumors
  • Peptide Receptor Radionuclide Therapy
  • Pediatric Neuroendocrine Tumors

Their expertise extends to radiation dosimetry and safety evaluations in young patients.

Long-term Safety Studies

The investigator focuses on post-authorization safety monitoring of radioligand therapies, with particular attention to long-term outcomes and potential adverse effects.

  • Treatment-Related Myelosuppression
  • Renal Function Monitoring
  • Secondary Malignancy Assessment

Their research includes extended follow-up studies spanning up to ten years post-treatment.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.